Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

被引:159
|
作者
Satin, Leslie S. [1 ]
Butler, Peter C. [2 ]
Ha, Joon [3 ]
Sherman, Arthur S. [3 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Brehm Diabet Res Ctr, Ann Arbor, MI 48105 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[3] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Islets; Oscillations; Insulin pulsatility; Insulin resistance; Diabetes; PANCREATIC BETA-CELLS; INDUCED ELECTRICAL-ACTIVITY; BURST MASS; IN-VIVO; METABOLIC OSCILLATIONS; CALCIUM OSCILLATIONS; GLUCAGON-SECRETION; CA2+ OSCILLATIONS; BASAL INSULIN; ION CHANNELS;
D O I
10.1016/j.mam.2015.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes (T2DM) results when increases in beta cell function and/or mass cannot compensate for rising insulin resistance. Numerous studies have documented the longitudinal changes in metabolism that occur during the development of glucose intolerance and lead to T2DM. However, the role of changes in insulin secretion, both amount and temporal pattern, has been understudied. Most of the insulin secreted from pancreatic beta cells of the pancreas is released in a pulsatile pattern, which is disrupted in T2DM. Here we review the evidence that changes in beta cell pulsatility occur during the progression from glucose intolerance to T2DM in humans, and contribute significantly to the etiology of the disease. We review the evidence that insulin pulsatility improves the efficacy of secreted insulin on its targets, particularly hepatic glucose production, but also examine evidence that pulsatility alters or is altered by changes in peripheral glucose uptake. Finally, we summarize our current understanding of the biophysical mechanisms responsible for oscillatory insulin secretion. Understanding how insulin pulsatility contributes to normal glucose homeostasis and is altered in metabolic disease states may help improve the treatment of T2DM. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:61 / 77
页数:17
相关论文
共 50 条
  • [31] Oxidative stress and impaired insulin secretion in type 2 diabetes
    Robertson, R. Paul
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) : 615 - 619
  • [32] Beneficial effects of bezafibrate on glucose tolerance and insulin secretion in rats with type 2 diabetes mellitus
    Hasegawa, N
    Ogawa, Y
    Tazawa, Y
    Umeda, Y
    Katayama, Y
    Nakamura, T
    Suda, T
    [J]. DIABETOLOGIA, 2000, 43 : A129 - A129
  • [33] Impaired glucose tolerance and progression to type 2 diabetes in youth
    Krakoff, J
    Hanson, R
    Touger, L
    Bennett, P
    Knowler, W
    [J]. DIABETES, 2003, 52 : A70 - A70
  • [34] Type 1 diabetes during pregnancy predisposes offspring to impaired glucose tolerance through impairment of insulin secretion with no alteration of insulin sensitivity
    Sobngwi, E
    Boudou, P
    Vexiau, P
    Leblanc, H
    Calvo, F
    Gautier, JF
    [J]. DIABETES, 2002, 51 : A332 - A332
  • [35] The Impact of a Family History of Type 2 Diabetes on Insulin Secretion and Insulin Sensitivity in Individuals With Varying Glucose Tolerance
    Li, Ping
    Zhang, Jing-Fan
    Li, Ling
    Liu, Yu-Hui
    Shi, Ying
    Wang, Li-Wei
    Gao, Jie-Qing
    Liu, Cong
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (01): : 22 - 27
  • [36] Effect of type 2 diabetes on meal tolerance and insulin secretion
    Basu, A
    Man, CD
    Toffollo, G
    Basu, R
    Cobelli, C
    Rizza, R
    [J]. DIABETES, 2004, 53 : A579 - A579
  • [37] IMPAIRED PULSATILE SECRETION OF INSULIN IN RELATIVES OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES
    ORAHILLY, S
    TURNER, RC
    MATTHEWS, DR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (19): : 1225 - 1230
  • [38] Effect of pioglitazone on first phase insulin secretion in type 2 diabetes mellitus and impaired glucose intolerance
    Zhao, TY
    Li, XJ
    Ren, XW
    [J]. DIABETES, 2003, 52 : A516 - A516
  • [39] Insulin secretion and impaired glucose tolerance in children with acanthosis nigricans
    Brickman, W
    Calhoun, J
    Metzger, B
    [J]. DIABETES, 2003, 52 : A70 - A70
  • [40] Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes
    Osei, K
    Gaillard, T
    Kaplow, J
    Bullock, M
    Schuster, D
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (12): : 1552 - 1557